These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 7613498)

  • 41. Systemic and regional hemodynamic effects of perindopril in congestive heart failure.
    Thuillez C; Richard C; Loueslati H; Auzepy P; Giudicelli JF
    J Cardiovasc Pharmacol; 1990 Apr; 15(4):527-35. PubMed ID: 1691380
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Adverse event with first-dose perindopril in congestive heart failure.
    MacFadyen RJ
    Lancet; 1997 Aug; 350(9076):520; author reply 521-2. PubMed ID: 9274605
    [No Abstract]   [Full Text] [Related]  

  • 43. Adverse event with first-dose perindopril in congestive heart failure.
    Cleland JG
    Lancet; 1997 Aug; 350(9076):520-1; author reply 521-2. PubMed ID: 9274607
    [No Abstract]   [Full Text] [Related]  

  • 44. Adverse event with first-dose perindopril in congestive heart failure.
    Lees KR; Reid JL
    Lancet; 1997 Aug; 350(9076):520; author reply 521-2. PubMed ID: 9274606
    [No Abstract]   [Full Text] [Related]  

  • 45. Adverse event with first-dose perindopril in congestive heart failure.
    Tan LB; Wright DJ
    Lancet; 1997 Aug; 350(9076):521. PubMed ID: 9274608
    [No Abstract]   [Full Text] [Related]  

  • 46. Effect of perindopril on physical function in elderly people with functional impairment: a randomized controlled trial.
    Sumukadas D; Witham MD; Struthers AD; McMurdo ME
    CMAJ; 2007 Oct; 177(8):867-74. PubMed ID: 17923654
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Perindopril and physiologic responses to exercise.
    Klug EQ; Joffe BI; Panz VR; Meyer TE; Fine BJ; Seftel HC
    J Cardiovasc Pharmacol; 1994 Jun; 23(6):864-8. PubMed ID: 7523776
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Relationship between mixed venous oxygen saturation and cardiac index in patients with chronic congestive heart failure.
    Richard C; Thuillez C; Pezzano M; Bottineau G; Giudicelli JF; Auzepy P
    Chest; 1989 Jun; 95(6):1289-94. PubMed ID: 2721268
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Should perindopril be used to treat patients with heart failure?
    Perdikis DA; Mangiaracina G
    Am Fam Physician; 2002 May; 65(9):1742, 1747. PubMed ID: 12018799
    [No Abstract]   [Full Text] [Related]  

  • 50. Effects of perindopril on soluble intercellular adhesion molecule-1 in patients with congestive heart failure.
    Wang XM; Li Y; Li HF; Liu F; Jia GL
    Heart; 2002 Oct; 88(4):417. PubMed ID: 12231609
    [No Abstract]   [Full Text] [Related]  

  • 51. Effect of cilazapril on exercise tolerance in congestive heart failure.
    Corder CN; Rubler S; Deere LF; Puls A; Peguero-Rivera A; Nagarajan R; Harwood W
    Pharmacology; 1993; 46(3):148-54. PubMed ID: 8441761
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Intrinsic alterations of diaphragm muscle in experimental cardiomyopathy.
    Lecarpentier Y; Pery N; Coirault C; Scalbert E; Desche P; Suard I; Lambert F; Chemla D
    Am Heart J; 1993 Sep; 126(3 Pt 2):770-6. PubMed ID: 8362752
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pharmacokinetics of perindopril in high-risk populations.
    Resplandy G; Genissel P
    J Cardiovasc Pharmacol; 1991; 18 Suppl 7():S9-18. PubMed ID: 1725203
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Effect of 12-Months Therapy With Perindopril A on Structural-Functional State of the Microcirculatory Vascular Bed in Patients With Chronic Heart Failure].
    Belenkov YN; Privalova EV; Danilogorodskaya YA; Zheleznykh EA; Shchendrygina AA; Tishman MI; Chekneva IS
    Kardiologiia; 2015 Dec; 55(12):5-10. PubMed ID: 28294758
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Treatment of chronic heart failure with perindopril in ethnic Sri Lankan patients.
    Thenabadu PN; Bulumulle J; Constantine GR
    Int J Cardiol; 1999 Apr; 69(1):109-10. PubMed ID: 10362383
    [No Abstract]   [Full Text] [Related]  

  • 56. Re: The PEP-CHF study.
    Sanderson JE
    Eur J Heart Fail; 2000 Mar; 2(1):117. PubMed ID: 10960267
    [No Abstract]   [Full Text] [Related]  

  • 57. [Utility of perindopril in mild-moderate heart failure in daily clinical practice. METRICA trial].
    Barrios Alonso V; Peña Pérez G; Campuzano Ruiz R; Lombera Romero F; Peralta Y
    Rev Clin Esp; 2003 Jan; 203(1):3-9. PubMed ID: 12605793
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Is there a new role for angiotensin-converting-enzyme inhibitors in elderly patients?
    Cranney A
    CMAJ; 2007 Oct; 177(8):891-2. PubMed ID: 17923657
    [No Abstract]   [Full Text] [Related]  

  • 59. Quality of drug advertisements in medical journals.
    Alliot L
    Lancet; 1997 Nov; 350(9091):1636. PubMed ID: 9393373
    [No Abstract]   [Full Text] [Related]  

  • 60. [Effects of perindopril on plasma soluble TRAIL and receptor soluble DR5 in patients with congestive heart failure].
    Hong Y; Li Y; Wang XM; Liu XS; Li YN; Ouyang WM; Chen CS; Jin BQ
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2003 Jul; 19(4):366-8. PubMed ID: 15163387
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.